trial · primary record
Zongertinib
Solid Tumours
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 588 |
| Primary completion | 2028-12-29 |
| Primary endpoint | Proportion of patients with objective response (OR) |
| Registry ID | NCT06581432 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:42:59.413Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06581432
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- ZONGERTINIB · approval
- Zongertinib · compound